What is the management for heavy bleeding postpartum (postpartum hemorrhage)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Postpartum Hemorrhage

Oxytocin is the first-line pharmacological treatment for postpartum hemorrhage (PPH), followed by tranexamic acid (TXA), which should be administered within 3 hours of birth for all women with clinically diagnosed PPH. 1

Definition and Diagnosis

  • PPH is defined as blood loss >500 mL after vaginal delivery or >1000 mL after cesarean section 1
  • Primary PPH occurs within 24 hours of delivery; secondary PPH occurs between 24 hours and 6 weeks postpartum 1
  • Objective measurement techniques (volumetric and gravimetric) should be used instead of visual estimation, which is notoriously inaccurate 1

Causes of PPH (Four T's)

  1. Tone (70-80% of cases): Uterine atony
  2. Trauma: Lacerations, hematomas, uterine inversion, uterine rupture
  3. Tissue: Retained placental tissue, placenta accreta spectrum disorders
  4. Thrombin: Coagulopathies 1, 2

Management Algorithm

First-Line Interventions

  1. Uterine massage and bimanual compression

  2. Oxytocin: First-line pharmacological treatment 1

    • Initial IV bolus followed by infusion
    • Higher doses (80 IU/500 mL over 1-4 hours) may be more effective than lower doses (10-30 IU) in preventing PPH 3
  3. Tranexamic acid (TXA):

    • Administer 1g IV over 10 minutes within 3 hours of birth
    • Give second dose if bleeding continues after 30 minutes 1

Second-Line Interventions (if bleeding persists)

  1. Additional uterotonics:

    • Methergine (ergometrine): For routine management after delivery of placenta; postpartum atony and hemorrhage 4
    • Carboprost tromethamine (Hemabate): For treatment of PPH due to uterine atony that hasn't responded to conventional management including IV oxytocin, uterine massage, and ergot preparations 5
    • Misoprostol: Alternative if other uterotonics unavailable 1
  2. Intrauterine balloon tamponade if pharmacological management fails 1

Third-Line Interventions

  1. Surgical interventions:

    • Uterine compression sutures
    • Uterine or internal iliac artery ligation
    • Hysterectomy (ultimate life-saving procedure) 1, 6
  2. Interventional radiology:

    • Arterial embolization if patient is hemodynamically stable and facilities available 1

Blood Product Management

  • Target hemoglobin >8 g/dL
  • Maintain fibrinogen levels >2 g/L (hypofibrinogenemia is most predictive of severe PPH) 1
  • If ongoing bleeding after 4 units of RBC, give 4 units of FFP and maintain 1:1 ratio until coagulation results available 1
  • Consider cryoprecipitate or fibrinogen concentrate if fibrinogen <2 g/L 1

Monitoring and Supportive Care

  • Continuous assessment of vital signs and blood loss
  • Administer oxygen in severe PPH
  • Prevent hypothermia (maintain body temperature >36°C) as clotting factors function poorly at lower temperatures 1
  • Use crystalloid fluids for initial volume replacement 1

Prevention Strategies

  • Active management of the third stage of labor:
    • Oxytocin administration after delivery of anterior shoulder (most important component)
    • Controlled cord traction
    • Uterine massage after placental delivery 2
  • Avoid routine episiotomy to decrease blood loss 2
  • Identify high-risk patients (previous PPH, advanced maternal age, prolonged labor, pre-eclampsia, obesity, multiple pregnancy, macrosomia) 7

Common Pitfalls and Caveats

  1. Delayed recognition: Objective measurement of blood loss is essential as visual estimation often underestimates actual loss
  2. Focusing only on uterine atony: Remember to systematically evaluate for all causes (Four T's)
  3. Delayed TXA administration: Must be given within 3 hours of birth for maximum benefit
  4. Inadequate team response: Rapid team-based care minimizes morbidity and mortality
  5. Overlooking coagulopathy: Monitor and correct fibrinogen levels promptly

Early recognition, systematic evaluation of causes, and prompt escalation of interventions following a structured approach are crucial for successful management of PPH and prevention of maternal morbidity and mortality.

References

Guideline

Postpartum Bleeding Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Postpartum Hemorrhage: Prevention and Treatment.

American family physician, 2017

Research

Postpartum haemorrhage: prevention and treatment.

Expert review of hematology, 2016

Research

Postpartum hemorrhage: epidemiology, risk factors, and causes.

Clinical obstetrics and gynecology, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.